product pipeline / R&D affecting expense
“Research and development 419,837 354,771 65,066 18 % Selling, general and administrative 105,497 92,144 13,353 14 % Total operating expenses 535,404 446,960 88,444 20 % Loss from operations (512,815) (446,879) (65,936) 15 % Interest and other income, net 29,420 33,038 (3,618) (11) % Loss on common stock issuance in private placement (40,258) — (40,258) 100 % Gain (loss) from change in fair value of warrants and earnout shares (284,424) 52,683 (337,107) (640) % Total other income (loss), net (295,262) 85,721 (380,983) (444) % Loss before income taxes (808,077) (361,158) (446,919) 124 % Income tax expense 229 599 (370) (62) % Net loss $ (808,306) $ (361,757) (446,549) 123 % Revenue Revenue increased by $22.5 million primarily due to the Blade acquisition, increased revenue from on-base operations for a DOD agency, and increased revenue from providing engineering services to third parties.”
JOBY 10-Q